BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Erivedge® (vismodegib): Labelling of the bottle and Package Leaflet

Active substance: vismodegib

Important information on the labelling of the bottle and the Package Leaflet as a precautionary measure to ensure safe administration.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 303KB, File is accessible